MassMutual Private Wealth & Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
EAM
EAM
SAM
WC
HWAM
PFSRSONJ
MassMutual Private Wealth & Trust's MDGL Position: Q2 2026 in Review
MassMutual Private Wealth & Trust increased its Madrigal Pharmaceuticals (MDGL) stake by 10% in Q2 2026, buying an estimated $512 and bringing the position to 11 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.
MassMutual Private Wealth & Trust first reported a position in MDGL in Q4 2021 and has held it in 12 quarters since. The position peaked at $7.29K in Q1 2025. 95 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- MassMutual Private Wealth & Trust held 11 shares of Madrigal Pharmaceuticals worth $5.91K as of Q2 2026.
- MassMutual Private Wealth & Trust bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
- Madrigal Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1612 holding.
- MassMutual Private Wealth & Trust first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
- MassMutual Private Wealth & Trust's Madrigal Pharmaceuticals position peaked at $7.29K in Q1 2025.
- 95 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.